Dopaminergic polymorphisms associated with time-on-task declines and fatigue in the psychomotor vigilance test

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Lim, Julian ^a   Ebstein, Richard ^a   Tse, Chun Yu ^a   Monakhov, Mikhail ^a   Lai, Poh San ^a   Dinges, David F ^b   Kwok, Kenneth ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTENTION; CATECHOL O METHYL TRANSFERASE GENE; CONTROLLED STUDY; DOPAMINE TRANSPORTER GENE; DOPAMINERGIC SYSTEM; DRD4 GENE; EXON; FATIGUE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; HUMAN EXPERIMENT; MENTAL PERFORMANCE; MOOD; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; PREFRONTAL CORTEX; PSYCHOMOTOR VIGILANCE TEST; SUSTAINED ATTENTION; TIME ON TASK EFFECT; VARIABLE NUMBER OF TANDEM REPEAT; ADOLESCENT; AROUSAL; DYSTHYMIA; FEMALE; GENETICS; MALE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; SINGLE NUCLEOTIDE POLYMORPHISM; TASK PERFORMANCE;

CATECHOL METHYLTRANSFERASE; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; DRD4 PROTEIN, HUMAN; PRIMER DNA; SLC6A3 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AROUSAL; BASE SEQUENCE; CATECHOL O-METHYLTRANSFERASE; DNA PRIMERS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; HUMANS; MALE; MENTAL FATIGUE; MINISATELLITE REPEATS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOMOTOR PERFORMANCE; RECEPTORS, DOPAMINE D4; TASK PERFORMANCE AND ANALYSIS; YOUNG ADULT;

EID: 84858393824     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033767     Document Type: Article

References (64)

1. Davies D, Parasuraman R, (1982) The Psychology of Vigilance: London: Academic.
2. See J, Howe S, Warm J, Dember W, (1995) A meta-analysis of the sensitivity decrement in vigilance. Psychol Bull 117: 230-249.
3. Warm JS, Parasuraman R, Matthews G, (2008) Vigilance requires hard mental work and is stressful. Hum Factors 50: 433-441.
4. Helton WS, Russell PN, (2011) Working memory load and the vigilance decrement. Exp Brain Res 212: 429-437.
5. Pattyn N, Neyt X, Henderickx D, Soetens E, (2008) Psychophysiological investigation of vigilance decrement: boredom or cognitive fatigue? Physiol Behav 93: 369-378.
6. Ossowski U, Malinen S, Helton WS, (2011) The effects of emotional stimuli on target detection: indirect and direct resource costs. Conscious Cogn 20: 1649-1658.
7. Helton WS, Russell PN, (2011) The effects of arousing negative and neutral picture stimuli on target detection in a vigilance task. Hum Factors 53: 132-141.
8. Landrigan CP, Rothschild JM, Cronin JW, Kaushal R, Burdick E, et al. (2004) Effect of reducing interns' work hours on serious medical errors in intensive care units. N Engl J Med 351: 1838-1848.
9. Dinges DF, (1995) An overview of sleepiness and accidents. J Sleep Res 4: 4-14.
10. Parasuraman R, (2009) Assaying individual differences in cogntition with molecular genetics: theory and application. Theoretical Issues in Ergonomic Science 10: 399-416.
11. Lim J, Wu WC, Wang J, Detre JA, Dinges DF, et al. (2010) Imaging brain fatigue from sustained mental workload: an ASL perfusion study of the time-on-task effect. Neuroimage 49: 3426-3435.
12. Bellgrove MA, Mattingley JB, (2008) Molecular genetics of attention. Ann N Y Acad Sci 1129: 200-212.
13. Rubia K, Overmeyer S, Taylor E, Brammer M, Williams SCR, et al. (1999) Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: A study with functional MRI. American Journal of Psychiatry 156: 891-896.
14. Casey BJ, Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, et al. (1997) Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 36: 374-383.
15. Solanto MV, (1998) Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 94: 127-152.
16. Spencer T, Wilens T, Biederman J, Faraone SV, Ablon JS, et al. (1995) A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry 52: 434-443.
17. Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, et al. (1995) Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56: 993-998.
18. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M, (1997) Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 2: 311-313.
19. Li DW, Sham PC, Owen MJ, He L, (2006) Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet 15: 2276-2284.
20. Manor I, Tyano S, Eisenberg J, Bachner-Melman R, Kotler M, et al. (2002) The short DRD4 repeats confer risk to attention deficit hyperactivity disorder in a family-based design and impair performance on a continuous performance test (TOVA). Mol Psychiatry 7: 790-794.
21. Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky E, Zohar A, et al. (1999) Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype. Am J Med Genet 88: 497-502.
22. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, et al. (1996) Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6: 243-250.
23. Kaufman S, Friedman S, (1965) Dopamine-Beta-Hydroxylase. Pharmacol Rev 17: 71-100.
24. Rodriguez-Jimenez R, Hoenicka J, Jimenez-Arriero MA, Ponce G, Bagney A, et al. (2006) Performance in the Wisconsin Card Sorting Test and the C957T polymorphism of the DRD2 gene in healthy volunteers. Neuropsychobiology 54: 166-170.
25. Grace AA, (1995) The tonic/phasic model of dopamine system regulation: its relevance for understanding how stimulant abuse can alter basal ganglia function. Drug Alcohol Depend 37: 111-129.
26. Demeter E, Hernandez-Garcia L, Sarter M, Lustig C, (2011) Challenges to attention: a continuous arterial spin labeling (ASL) study of the effects of distraction on sustained attention. Neuroimage 54: 1518-1529.
27. Thierry AM, Blanc G, Sobel A, Stinus L, Golwinski J, (1973) Dopaminergic terminals in the rat cortex. Science 182: 499-501.
28. Cornish KM, Manly T, Savage R, Swanson J, Morisano D, et al. (2005) Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample. Mol Psychiatry 10: 686-698.
29. Bellgrove MA, Hawi Z, Gill M, Robertson IH, (2006) The cognitive genetics of attention deficit hyperactivity disorder (ADHD): sustained attention as a candidate phenotype. Cortex 42: 838-845.
30. Bellgrove MA, Hawi Z, Kirley A, Gill M, Robertson IH, (2005) Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype. Neuropsychologia 43: 1847-1857.
31. Bellgrove MA, Domschke K, Hawi Z, Kirley A, Mullins C, et al. (2005) The methionine allele of the COMT polymorphism impairs prefrontal cognition in children and adolescents with ADHD. Exp Brain Res 163: 352-360.
32. Blasi G, Mattay VS, Bertolino A, Elvevag B, Callicott JH, et al. (2005) Effect of catechol-O-methyltransferase val158met genotype on attentional control. J Neurosci 25: 5038-5045.
33. Fossella J, Sommer T, Fan J, Wu Y, Swanson JM, et al. (2002) Assessing the molecular genetics of attention networks. BMC Neurosci 3: 14.
34. Dinges D, Powell J, (1985) Microcomputer analyses of performance on a portable, simple visual RT task during sustained operations. Beh Res Meth Instr Comp 17: 652-655.
35. Basner M, Dinges DF, (2011) Maximizing Sensitivity of the Psychomotor Vigilance Test (PVT) to Sleep Loss. Sleep 34: 581-591.
36. Lim J, Dinges DF, (2008) Sleep deprivation and vigilant attention. Ann N Y Acad Sci 1129: 305-322.
37. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ, (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28: 193-213.
38. Dorrian J, Rogers NL, Dinges DF, (2005) Psychomotor vigilance performance: A neurocognitive assay sensitive to sleep loss. In: Kushida C, editors. Sleep Deprivation: Clinical Issues, Pharmacology and Sleep Loss Effects New York, NY Marcel Dekker, Inc pp. 39-70.
39. Giambra LM, Quilter RE, (1987) A two-term exponential functional description of the time course of sustained attention. Hum Factors 29: 635-643.
40. Doran SM, Van Dongen HP, Dinges DF, (2001) Sustained attention performance during sleep deprivation: evidence of state instability. Arch Ital Biol 139: 253-267.
41. Castellanos FX, Sonuga-Barke EJ, Scheres A, Di Martino A, Hyde C, et al. (2005) Varieties of attention-deficit/hyperactivity disorder-related intra-individual variability. Biol Psychiatry 57: 1416-1423.
42. Bearden CE, Jawad AF, Lynch DR, Sokol S, Kanes SJ, et al. (2004) Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. Am J Psychiatry 161: 1700-1702.
43. Fossella J, Sommer T, Fan J, Wu YH, Swanson JM, et al. (2002) Assessing the molecular genetics of attention networks. Bmc Neuroscience 3.
44. Goto Y, Otani S, Grace AA, (2007) The Yin and Yang of dopamine release: a new perspective. Neuropharmacology 53: 583-587.
45. Grace AA, Bunney BS, (1984) The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4: 2877-2890.
46. May LJ, Kuhr WG, Wightman RM, (1988) Differentiation of dopamine overflow and uptake processes in the extracellular fluid of the rat caudate nucleus with fast-scan in vivo voltammetry. J Neurochem 51: 1060-1069.
47. Grace AA, Bunney BS, (1984) The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci 4: 2866-2876.
48. Keefe KA, Zigmond MJ, Abercrombie ED, (1993) In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acids. J Neural Transm Gen Sect 91: 223-240.
49. Heikkila RE, Orlansky H, Cohen G, (1975) Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. Biochem Pharmacol 24: 847-852.
50. Brody AL, Olmstead RE, London ED, Farahi J, Meyer JH, et al. (2004) Smoking-induced ventral striatum dopamine release. Am J Psychiatry 161: 1211-1218.
51. Dreher JC, Burnod Y, (2002) An integrative theory of the phasic and tonic modes of dopamine modulation in the prefrontal cortex. Neural Netw 15: 583-602.
52. da Silva N Jr, Szobot CM, Anselmi CE, Jackowski AP, Chi SM, et al. (2011) Attention deficit/hyperactivity disorder: is there a correlation between dopamine transporter density and cerebral blood flow? Clin Nucl Med 36: 656-660.
53. Goldberg TE, Weinberger DR, (2004) Genes and the parsing of cognitive processes. Trends Cogn Sci 8: 325-335.
54. Parasuraman R, Jiang Y, (2011) Individual differences in cognition, affect, and performance: Behavioral, neuroimaging, and molecular genetic approaches. Neuroimage 59: 70-82.
55. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, et al. (2004) Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75: 807-821.
56. Yavich L, Forsberg MM, Karayiorgou M, Gogos JA, Mannisto PT, (2007) Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum. J Neurosci 27: 10196-10209.
57. Bilder RM, Volavka J, Lachman HM, Grace AA, (2004) The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29: 1943-1961.
58. Thayer RE, (1989) The Biopsychology of Mood and Arousal New York, NY Oxford University Press.
59. Malyuchenko NV, Schegolkova JV, Kulikova MA, Timofeeva MA, Shlepzova VA, et al. (2010) Effects of genetic variations in the dopaminergic system on fatigue in humans: gender aspects. Bull Exp Biol Med 149: 226-232.
60. Stahl SM, (2002) The psychopharmacology of energy and fatigue. J Clin Psychiatry 63: 7-8.
61. Verhoeff NP, Christensen BK, Hussey D, Lee M, Papatheodorou G, et al. (2003) Effects of catecholamine depletion on D2 receptor binding, mood, and attentiveness in humans: a replication study. Pharmacol Biochem Behav 74: 425-432.
62. Carter RC, Krause M, Harbeson MM, (1986) Beware the Reliability of Slope Scores for Individuals. Hum Factors 28: 673-683.
63. Posner MI, (2011) Expanding horizons in ergonomics research. Neuroimage 59: 149-153.
64. Parasuraman R, Wilson GF, (2008) Putting the brain to work: neuroergonomics past, present, and future. Hum Factors 50: 468-474.